Some poorly differentiated pRCCs, such as those with type 2 pathology and a large size, may present with heterogeneous enhancement due to necrosis or haemorrhage within the tumour [35], therefore it is difficult to be differential diagnosis from Xp11.2/TFE3 RCC. This evidence concerns the gene TFE3 and renal cell carcinoma.